Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
inhaler |
| gptkbp:activeIngredient |
gptkb:fluticasone_propionate
|
| gptkbp:ATCCode |
R03BA05
|
| gptkbp:compatibleWith |
acute asthma attack
|
| gptkbp:contains |
propellant
|
| gptkbp:countryOfOperation |
gptkb:Australia
gptkb:New_Zealand gptkb:United_Kingdom |
| gptkbp:drugClass |
gptkb:Corticosteroid
|
| gptkbp:form |
metered-dose inhaler
|
| https://www.w3.org/2000/01/rdf-schema#label |
Flixotide Evohaler
|
| gptkbp:indication |
maintenance treatment of asthma
prevention of asthma symptoms |
| gptkbp:manufacturer |
GlaxoSmithKline
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
inhalation
|
| gptkbp:sideEffect |
sore throat
oral thrush hoarseness |
| gptkbp:strengthsAvailable |
250 mcg
50 mcg 125 mcg |
| gptkbp:usedFor |
asthma
chronic obstructive pulmonary disease |
| gptkbp:bfsParent |
gptkb:Flovent_HFA
|
| gptkbp:bfsLayer |
8
|